The approach targets and chelates excess succinate in IBD patients to attenuate its absorption, by using peptide sequences that mimic the succinate binding site in succinate binding enzymes.
Levels of succinate, a metabolic molecule involved in various biochemical processes in living cells, were markedly increased in IBD, corresponding to changes in succinate-metabolizing gut bacteria.
Novel IBD Treatment Strategy Seeks to Sequester Inflammation-Inducing Metabolite clinicalomics.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicalomics.com Daily Mail and Mail on Sunday newspapers.